查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1500426

寡核苷酸合成市场：按产品类型、应用和最终用户划分 - 全球预测 2024-2030

Oligonucleotide Synthesis Market by Product (Equipment, Linkers & Adaptor, Probes), Type (Custom, Pre-designed), Application, End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年寡核苷酸合成市场规模为102.9亿美元，2024年达122.4亿美元，预计2030年将达374.1亿美元，复合年增长率为20.24%。

寡核苷酸合成是一种自动组装单链DNA 或 RNA 分子（称为寡核苷酸）的化学过程。该过程用于多种应用，包括研究和开发、药物发现、基因治疗和法医学。世界各地慢性疾病的日益流行推动了药物发现和研究活动，促进了寡核苷酸合成过程的使用，以开发有效的药物和疗法。增加对製药和生物技术研究的投资正在扩大寡核苷酸合成工艺，以创建可用于靶向基因表现、诊断测试和治疗剂的自订核酸序列。然而，大规模寡核苷酸合成的高生产成本和挑战可能会对寡核苷酸合成过程在最终用途领域的使用产生负面影响。此外，扩大寡核苷酸开发的持续改进和合作预计将促进全球最终用途产业对寡核苷酸合成製程的使用。

主要市场统计
基准年[2023] 102.9亿美元
预测年份 [2024] 122.4亿美元
预测年份 [2030] 374.1亿美元
复合年增长率（%） 20.24%

区域洞察

在美洲，由于医疗保健行业的成熟、药物和治疗研究活动的增加以及对改进的诊断测试解决方案的需求不断增长，寡核苷酸合成市场正在发展。慢性病盛行率的上升、政府对医疗基础设施现代化的措施和投资，以及药物发现和研究的增加，正在推动该地区最终用途领域寡合成製程的使用。由于生物技术和药物研究投资的增加、诊断和治疗领域对合成寡核苷酸的需求不断增长以及全部区域基因组研究的扩展，亚太市场正在经历显着增长。对早期有效疾病诊断的需求日益增长，生命科学和医学研究的扩展，以及对开发改进的诊断解决方案的日益关注，正在加速欧洲、中东和非洲地区的研究机构和诊断实验室对寡核苷酸合成製程的使用。此外，旨在最大限度地减少错误并提高寡核苷酸合成过程的品质和效率的持续研究预计将推动寡核苷酸合成市场的全球成长。

FPNV定位矩阵

FPNV定位矩阵对于评估供应商在寡核苷酸合成市场的定位至关重要。此矩阵提供了对供应商的全面评估，并检查了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果，供应商被分为代表其成功程度的四个像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对寡核苷酸合成市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献，您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他关键指标。此外，该分析还提供了对该行业竞争性质的宝贵见解，包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息，供应商可以做出更明智的决策并製定有效的策略，以在市场竞争中保持领先地位。

策略分析与建议

策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前在寡核苷酸合成市场中的地位进行全面评估，使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析，以确定核心优势和需要改进的领域。

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 更关注慢性病的传播与新药发现
      • 合成寡核苷酸在分子诊断和临床应用的使用越来越多
      • 对製药和生物技术研究的大量投资
    • 抑制因素
      • 寡核苷酸生产高成本
    • 机会
      • 寡核苷酸合成的改进与进步
      • 策略联盟增加寡核苷酸产量
    • 任务
      • 与大规模寡核苷酸合成相关的併发症
  • 市场区隔分析
    • 产品：增加使用合成寡核苷酸来支持研究和治疗设计
    • 最终用户：寡核苷酸合成对于学术研究机构新科学技术发展的巨大潜力
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章寡核苷酸合成市场：副产品

  • 装置
  • 连接子和适配器
  • 探测
  • 试剂/耗材
  • 服务
  • 合成寡核苷酸

第七章寡核苷酸合成市场：依类型

  • 自订
  • 预先设计的

第八章寡核苷酸合成市场：依应用分类

  • 诊断
  • 调查
  • 治疗性的

第九章寡核苷酸合成市场：依最终用户分类

  • 学术研究所
  • 合约研究官（CRO）和首席行销长（CMO）
  • 诊断实验室和医院
  • 製药和生物技术公司

第十章美洲寡核苷酸合成市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太寡核苷酸合成市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东和非洲寡核苷酸合成市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Codexis 推出生态合成平台以增强寡核苷酸生产
    • Corden Pharma 在科罗拉多进行策略性扩张，提高寡核苷酸产量
    • Oligo Factory 开设先进的寡核苷酸生产设施
    • 英国创新合作旨在改变寡核苷酸生产
    • 安捷伦科技扩大寡核苷酸产能
    • Aurisco 和 Cytiva推出中国首款 Oligo FlexFactory
    • 无锡 STA 在中国开设新的寡核苷酸和胜肽生产设施
  • 战略分析和建议

第14章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-0A609A26A918

[192 Pages Report] The Oligonucleotide Synthesis Market size was estimated at USD 10.29 billion in 2023 and expected to reach USD 12.24 billion in 2024, at a CAGR 20.24% to reach USD 37.41 billion by 2030.

Oligonucleotide synthesis is a chemical process that involves the automated assembly of single-stranded DNA or RNA molecules, referred to as oligonucleotides. This process is used in various applications, including research and development, drug discovery, gene therapy, and forensic science. The rising prevalence of chronic diseases worldwide is resulting in increased drug discovery and research activities and is facilitating the use of the oligonucleotide synthesis process to develop efficient drugs and therapeutics. The increasing investments in pharmaceutical and biotechnology research are expanding oligonucleotide synthesis processes to create custom nucleic acid sequences that can be used for targeted gene expression, diagnostic testing, and therapeutic agents. However, the high cost of production and issues in large-scale oligonucleotide synthesis may adversely impact the end-use sectors' use of the oligonucleotide synthesis process. Moreover, the ongoing improvements and collaboration to expand the development of oligonucleotides are expected to encourage the use of the oligonucleotide synthesis processes by end-use industries worldwide.

KEY MARKET STATISTICS
Base Year [2023] USD 10.29 billion
Estimated Year [2024] USD 12.24 billion
Forecast Year [2030] USD 37.41 billion
CAGR (%) 20.24%

Regional Insights

The oligonucleotide synthesis market is evolving in the Americas owing to a well-established healthcare sector, increasing drug and therapeutic research activities, and a growing need for improved diagnostic testing solutions. The rising prevalence of chronic diseases, government initiatives and investments in modernizing healthcare infrastructure, and increasing drug discovery and research are facilitating the use of the oligo synthesis process across the end-use sectors in the region. The Asia-Pacific oligonucleotide synthesis market is experiencing significant growth due to increasing investments in biotechnology and pharmaceutical research, rising demand for synthetic oligonucleotides in diagnostics and therapeutics, and the expansion of genomic studies across the region. The growing need for early and efficient disease diagnosis, expanding life-science and medical research, and growing focus on developing improved diagnostic solutions are accelerating the use of the oligonucleotide synthesis processes by the research institutes and diagnostic laboratories in the EMEA region. Additionally, the ongoing research to minimize errors and enhance the quality and efficiency of the oligonucleotide synthesis process is anticipated to propel the growth of the oligonucleotide synthesis market worldwide.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Oligonucleotide Synthesis Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Prevalence of chronic diseases and growing focus on drug discovery
      • Rising usage of synthesized oligonucleotides in molecular diagnostics and clinical applications
      • Significant investments in pharmaceutical and biotechnology research
    • Market Restraints
      • High cost of oligonucleotides production
    • Market Opportunities
      • Improvements and advances in oligonucleotide synthesis
      • Strategic alliances for increasing production of oligonucleotides
    • Market Challenges
      • Complications associated with large scale oligonucleotide synthesis
  • Market Segmentation Analysis
    • Product: Growing usage of synthesized oligonucleotides for aiding research and treatment design
    • End-User: High potential of oligonucleotide synthesis among academic research institutes for developing new scientific techniques
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Oligonucleotide Synthesis Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Oligonucleotide Synthesis Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Codexis Introduces Eco Synthesis Platform for Enhanced Oligonucleotide Manufacturing

Codexis unveiled their new Eco Synthesis Platform for large-scale protein synthesis. This innovative platform is designed to enable high-throughput production of oligonucleotide sequences at an industrial scale, allowing for increased throughput, manufacturing speed, and cost savings. The platform can be used to produce longer strands of DNA or RNA with more consistency than ever before. [Published On: 2023-05-10]

CordenPharma Enhances Oligonucleotide Production with Strategic Expansion in Colorado

CordenPharma took a major step into the oligonucleotide manufacturing industry with the announcement of their two-phase investment at CordenPharma Colorado. This expansion project adds two additional suites, potentially doubling their current production capacity for oligonucleotides, allowing them to better serve their customers with high-quality products in a timely manner. The investments also bring advanced process engineering and analytical labs, thus ensuring that all product specifications are met with precision and accuracy. [Published On: 2023-05-02]

Oligo Factory Launches Advanced Oligonucleotide Production Facility

Oligo Factory opened a new state-of-the-art oligonucleotide manufacturing facility, which features modernized production processes and equipment that is expected to increase the speed and reliability of supplying custom oligos to their customers. [Published On: 2023-03-02]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Oligonucleotide Synthesis Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Oligonucleotide Synthesis Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Ajinomoto Bio-Pharma Services, ATDBio Ltd., Bio-synthesis Inc., Biocomma Ltd., Biolegio B.V., Biolytic Lab Performance Inc., Bioserve India by Reprocell Group, Bon Opus Biosciences, LLC, Creative Biogene, Cusabio Technology LLC, Danaher Corporation, Eurofins Genomics LLC, Eurogentec S.A. by Kaneka Corporation, GE Healthcare Inc., Generi Biotech, Genscript Corporation, Hongene Biotech Corp., LGC Genomics Limited, Merck KGaA, Microsynth AG, Nitto Denko Avecia Inc., Novartis AG, PerkinElmer, Inc., Synbio Technologies, TAG Copenhagen A/S, TCI Chemicals (India) Pvt. Ltd., Thermo Fisher Scientific Inc., and TriLink BioTechnologies, Inc..

Market Segmentation & Coverage

This research report categorizes the Oligonucleotide Synthesis Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Equipment
    • Linkers & Adaptor
    • Probes
    • Reagents & Consumables
    • Services
    • Synthesized Oligonucleotides
  • Type
    • Custom
    • Pre-designed
  • Application
    • Diagnostic
    • Research
    • Therapeutic
  • End-User
    • Academic Research Institutes
    • CROs & CMOs
    • Diagnostic Laboratories & Hospitals
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of chronic diseases and growing focus on drug discovery
      • 5.1.1.2. Rising usage of synthesized oligonucleotides in molecular diagnostics and clinical applications
      • 5.1.1.3. Significant investments in pharmaceutical and biotechnology research
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of oligonucleotides production
    • 5.1.3. Opportunities
      • 5.1.3.1. Improvements and advances in oligonucleotide synthesis
      • 5.1.3.2. Strategic alliances for increasing production of oligonucleotides
    • 5.1.4. Challenges
      • 5.1.4.1. Complications associated with large scale oligonucleotide synthesis
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Growing usage of synthesized oligonucleotides for aiding research and treatment design
    • 5.2.2. End-User: High potential of oligonucleotide synthesis among academic research institutes for developing new scientific techniques
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Oligonucleotide Synthesis Market, by Product

  • 6.1. Introduction
  • 6.2. Equipment
  • 6.3. Linkers & Adaptor
  • 6.4. Probes
  • 6.5. Reagents & Consumables
  • 6.6. Services
  • 6.7. Synthesized Oligonucleotides

7. Oligonucleotide Synthesis Market, by Type

  • 7.1. Introduction
  • 7.2. Custom
  • 7.3. Pre-designed

8. Oligonucleotide Synthesis Market, by Application

  • 8.1. Introduction
  • 8.2. Diagnostic
  • 8.3. Research
  • 8.4. Therapeutic

9. Oligonucleotide Synthesis Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic Research Institutes
  • 9.3. CROs & CMOs
  • 9.4. Diagnostic Laboratories & Hospitals
  • 9.5. Pharmaceutical & Biotechnology Companies

10. Americas Oligonucleotide Synthesis Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Oligonucleotide Synthesis Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Oligonucleotide Synthesis Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Codexis Introduces Eco Synthesis Platform for Enhanced Oligonucleotide Manufacturing
    • 13.3.2. CordenPharma Enhances Oligonucleotide Production with Strategic Expansion in Colorado
    • 13.3.3. Oligo Factory Launches Advanced Oligonucleotide Production Facility
    • 13.3.4. UK's Innovative Collaboration Aims to Transform Oligonucleotide Production
    • 13.3.5. Agilent Technologies Expands Oligonucleotide Production Capacity
    • 13.3.6. Aurisco and Cytiva Launch China's First Oligo FlexFactory
    • 13.3.7. Wuxi STA Expands with New Oligonucleotide and Peptide Production Facility in China
  • 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. OLIGONUCLEOTIDE SYNTHESIS MARKET RESEARCH PROCESS
  • FIGURE 2. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. OLIGONUCLEOTIDE SYNTHESIS MARKET DYNAMICS
  • FIGURE 7. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. OLIGONUCLEOTIDE SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. OLIGONUCLEOTIDE SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. OLIGONUCLEOTIDE SYNTHESIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY LINKERS & ADAPTOR, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY LINKERS & ADAPTOR, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PROBES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PROBES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SERVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SERVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIZED OLIGONUCLEOTIDES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIZED OLIGONUCLEOTIDES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY CUSTOM, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY CUSTOM, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRE-DESIGNED, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRE-DESIGNED, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTIC, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY CROS & CMOS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY CROS & CMOS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES & HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES & HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 46. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 47. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 48. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 49. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 50. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 55. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 56. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 57. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 58. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 59. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 60. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 61. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 62. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 63. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 64. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 65. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 66. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 67. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 68. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 69. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 70. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 71. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 72. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 73. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 74. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 75. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 76. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 77. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 78. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 79. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 80. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 81. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 82. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 83. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 84. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 85. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 86. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 87. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 88. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 89. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 90. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 91. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 92. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 93. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 94. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 95. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 96. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 107. AUSTRALIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 108. AUSTRALIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 109. AUSTRALIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 110. AUSTRALIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 112. AUSTRALIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 114. AUSTRALIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 115. CHINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 116. CHINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 117. CHINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 118. CHINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 119. CHINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 120. CHINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 121. CHINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 122. CHINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 123. INDIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 124. INDIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 125. INDIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 126. INDIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 127. INDIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 128. INDIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 129. INDIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 130. INDIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 131. INDONESIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 132. INDONESIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 133. INDONESIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 134. INDONESIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 135. INDONESIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 136. INDONESIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 137. INDONESIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 138. INDONESIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 139. JAPAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 140. JAPAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 141. JAPAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 142. JAPAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 143. JAPAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 144. JAPAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 145. JAPAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 146. JAPAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 147. MALAYSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 148. MALAYSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 149. MALAYSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 150. MALAYSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 151. MALAYSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 152. MALAYSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 153. MALAYSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 154. MALAYSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 155. PHILIPPINES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 156. PHILIPPINES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 157. PHILIPPINES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 158. PHILIPPINES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 159. PHILIPPINES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 160. PHILIPPINES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 161. PHILIPPINES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 162. PHILIPPINES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 163. SINGAPORE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 164. SINGAPORE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 165. SINGAPORE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 166. SINGAPORE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 167. SINGAPORE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 168. SINGAPORE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 169. SINGAPORE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 170. SINGAPORE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 171. SOUTH KOREA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 172. SOUTH KOREA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 173. SOUTH KOREA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 174. SOUTH KOREA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 175. SOUTH KOREA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 176. SOUTH KOREA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 177. SOUTH KOREA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 178. SOUTH KOREA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 179. TAIWAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 180. TAIWAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 181. TAIWAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 182. TAIWAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 183. TAIWAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 184. TAIWAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 185. TAIWAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 186. TAIWAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 187. THAILAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 188. THAILAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 189. THAILAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 190. THAILAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 191. THAILAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 192. THAILAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 193. THAILAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 194. THAILAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 195. VIETNAM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 196. VIETNAM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 197. VIETNAM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 198. VIETNAM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 199. VIETNAM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 200. VIETNAM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 201. VIETNAM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 202. VIETNAM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 213. DENMARK OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 214. DENMARK OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 215. DENMARK OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 216. DENMARK OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 217. DENMARK OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 218. DENMARK OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 219. DENMARK OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 220. DENMARK OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 221. EGYPT OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 222. EGYPT OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 223. EGYPT OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 224. EGYPT OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 225. EGYPT OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 226. EGYPT OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 227. EGYPT OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 228. EGYPT OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 229. FINLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 230. FINLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 231. FINLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 232. FINLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 233. FINLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 234. FINLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 235. FINLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 236. FINLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 237. FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 238. FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 239. FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 240. FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 241. FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 242. FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 243. FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 244. FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 245. GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 246. GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 247. GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 248. GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 249. GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 250. GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 251. GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 252. GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 253. ISRAEL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 254. ISRAEL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 255. ISRAEL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 256. ISRAEL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 257. ISRAEL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 258. ISRAEL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 259. ISRAEL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 260. ISRAEL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 261. ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 262. ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 263. ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 264. ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 265. ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 266. ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 267. ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 268. ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 269. NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 270. NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 271. NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 272. NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 273. NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 274. NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 275. NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 276. NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 277. NIGERIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 278. NIGERIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 279. NIGERIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 280. NIGERIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 281. NIGERIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 282. NIGERIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 283. NIGERIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 284. NIGERIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 285. NORWAY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 286. NORWAY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 287. NORWAY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 288. NORWAY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 289. NORWAY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 290. NORWAY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 291. NORWAY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 292. NORWAY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 293. POLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 294. POLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 295. POLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 296. POLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 297. POLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 298. POLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 299. POLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 300. POLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 301. QATAR OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 302. QATAR OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 303. QATAR OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 304. QATAR OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 305. QATAR OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 306. QATAR OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 307. QATAR OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 308. QATAR OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 309. RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 310. RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 311. RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 312. RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 313. RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 314. RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 315. RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 316. RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 317. SAUDI ARABIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 318. SAUDI ARABIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 319. SAUDI ARABIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 320. SAUDI ARABIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 321. SAUDI ARABIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 322. SAUDI ARABIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 323. SAUDI ARABIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 324. SAUDI ARABIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 325. SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 326. SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 327. SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 328. SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 329. SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 330. SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 331. SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 332. SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 333. SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 334. SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 335. SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 336. SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 337. SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 338. SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 339. SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END